EP 0833896 A1 19980408 - RECOMBINANT ADENOVIRUSES, USE THEREOF FOR PREPARING AAVS, COMPLEMENTARY CELL LINE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID ADENOVIRUSES
Title (en)
RECOMBINANT ADENOVIRUSES, USE THEREOF FOR PREPARING AAVS, COMPLEMENTARY CELL LINE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID ADENOVIRUSES
Title (de)
REKOMBINANTE ADENOVIRUS,IHRE VERWENDUNG ZUR HERSTELLUNG VON AAV,ZUR KOMPLEMENTATION FALIGE ZELLINIE UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
Title (fr)
ADENOVIRUS RECOMBINANTS, LEUR UTILISATION POUR PREPARER DES AAV, LIGNEE CELLULAIRE COMPLEMENTAIRE ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
Publication
Application
Priority
- FR 9507570 A 19950623
- FR 9600968 W 19960620
Abstract (en)
[origin: US2003039634A1] A recombinant adenovirus in which the expression of a nucleic acid sequence coding for at least one homologous or heterologous gene of viral origin is placed under the control of an inducible promoter, is disclosed. The use of such recombinant adenoviruses for preparing AAVs, and a complementary cell line and preparation method therefor, are also disclosed. Furthermore, pharmaceutical compositions containing such an adenovirus are disclosed.
IPC 1-7
IPC 8 full level
A61K 35/76 (2006.01); A61K 48/00 (2006.01); C12N 5/10 (2006.01); C12N 7/00 (2006.01); C12N 7/01 (2006.01); C12N 15/09 (2006.01); C12N 15/63 (2006.01); C12N 15/861 (2006.01); C12N 15/864 (2006.01)
CPC (source: EP KR US)
C12N 5/10 (2013.01 - KR); C12N 7/00 (2013.01 - KR); C12N 15/63 (2013.01 - EP US); C12N 15/86 (2013.01 - EP US); C12N 2710/10343 (2013.01 - EP US); C12N 2710/10344 (2013.01 - EP US); C12N 2710/16622 (2013.01 - EP US); C12N 2750/14122 (2013.01 - EP US); C12N 2750/14143 (2013.01 - EP US); C12N 2830/003 (2013.01 - EP US); C12N 2830/15 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
US 2003039634 A1 20030227; US 7033826 B2 20060425; AU 6363996 A 19970122; AU 716508 B2 20000224; BR 9608965 A 19990629; CA 2222270 A1 19970109; CZ 295934 B6 20051214; CZ 413097 A3 19980318; EP 0833896 A1 19980408; FR 2735789 A1 19961227; FR 2735789 B1 19970725; HU 224679 B1 20051228; HU P9900050 A1 19990428; HU P9900050 A3 20010828; IL 122710 A0 19980816; IL 122710 A 20061005; JP 3821846 B2 20060913; JP H11507835 A 19990713; KR 100514070 B1 20051221; KR 19990028307 A 19990415; MX 9709549 A 19980331; NO 975953 D0 19971218; NO 975953 L 19971218; SK 174297 A3 19980909; US 2002098165 A1 20020725; US 6420170 B1 20020716; WO 9700947 A1 19970109; ZA 965306 B 19970124
DOCDB simple family (application)
US 12161602 A 20020415; AU 6363996 A 19960620; BR 9608965 A 19960630; CA 2222270 A 19960620; CZ 413097 A 19960620; EP 96922971 A 19960620; FR 9507570 A 19950623; FR 9600968 W 19960620; HU P9900050 A 19960620; IL 12271096 A 19960609; IL 12271097 A 19960609; JP 50363797 A 19960620; KR 19970709621 A 19971222; MX 9709549 A 19960620; NO 975953 A 19971218; SK 174297 A 19960620; US 98135497 A 19971219; US 98135497 D 19971219; ZA 965306 A 19960621